Repligen (RGEN) Gains from Investment Securities (2010 - 2026)
Repligen (RGEN) reported Gains from Investment Securities of -$146000.0 for Q1 2026, down 112.15% year-over-year from $1.2 million in Q1 2025, and down 103.22% quarter-over-quarter from $4.5 million in Q4 2025.
Repligen (RGEN) Gains from Investment Securities (2010 - 2026) Analysis & Trends
Repligen (RGEN) has 17 years of Gains from Investment Securities data on file, last reported at -$146000.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at -$146000.0, down 112.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.7 million (down 641.87% YoY), and the FY2025 annual result was $563273.0, down 5.52% from the prior year.
- Gains from Investment Securities slipped to -$146000.0 in Q1 2026 per RGEN's latest filing, from $4.5 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $24.6 million in Q4 2022 and troughed at -$7.9 million in Q2 2025.
- A 5-year average of $1.3 million and a median of $39451.0 in 2024 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2025: Gains from Investment Securities soared 23433.33% in 2022, then plunged 105620.22% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $24.6 million in 2022, then sank by 86.95% to $3.2 million in 2023, then sank by 193.17% to -$3.0 million in 2024, then soared by 251.76% to $4.5 million in 2025, then tumbled by 103.22% to -$146000.0 in 2026.
- Business Quant data shows RGEN's Gains from Investment Securities at -$146000.0 in Q1 2026, $4.5 million in Q4 2025, and -$4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Repligen | 7.41 Bn | 6.42 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -146,000.00 |
| Mar 31, 2026 | -146,000.00 |
| Dec 31, 2025 | 4.53 Mn |
| Dec 31, 2025 | 4.53 Mn |
| Sep 30, 2025 | -4.15 Mn |
| Sep 30, 2025 | -4.15 Mn |
| Jun 30, 2025 | -7.94 Mn |
| Jun 30, 2025 | -7.94 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | -2.99 Mn |
| Dec 31, 2024 | -2.99 Mn |
| Sep 30, 2024 | 3,931.00 |
| Sep 30, 2024 | 3,931.00 |
| Mar 31, 2024 | 39,451.00 |
| Mar 31, 2024 | 39,451.00 |
| Dec 31, 2023 | 3.21 Mn |
| Dec 31, 2023 | 3.21 Mn |
| Sep 30, 2023 | 175,475.00 |
| Sep 30, 2023 | 175,475.00 |